Weekly News Roundup – Alzheimer’s Breakthroughs, Cancer Trial Advances, and High-Stakes Policy Battles

This week’s tHEORetically Speaking News Roundup covers semaglutide’s potential in Alzheimer’s treatment, Delcath’s new Phase II trial for colorectal cancer, and a court ruling overturning limits on Medicare Advantage broker payments. We also break down CVS’s $290 million penalty for Medicare drug overcharges and the Supreme Court’s decision upholding NIH grant cuts tied to DEI policies.

 Tune in for this concise recap of the week’s most impactful industry updates!